News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Somnomed.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Somnomed spins fairytale of a sleep cure in half-year results
Health & Biotech
Health: Oventus isn’t sleeping on the job because it’s making too much money
Health & Biotech
Dr Boreham’s Crucible: ResMed turbo-charges its sleep apnoea devices, races into new markets
Stockhead TV
VIDEO: The boom continues – 2019 tech sector wrap
Health & Biotech
My bank balance is bigger than yours: biotech quarterlies
Health & Biotech
Dr Boreham’s Crucible: How SomnoMed is placed in the $10.4 billion sleep apnoea market
Health & Biotech
Zoono is a $24m company. It just sold $33m worth of product
News
Quarterlies: Marley Spoon is spending now to profit later, aims to break even by 2020
Health & Biotech
A big Somnomed client just went out of business, but it’s not in Europe so it’s fine
Health & Biotech
